Navigation Links
Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance
Date:12/16/2009

Looking for the ultimate CHO cell culture supplement? InVitria has what scientists have been asking for! Zap-CHO is a robust CHO cell culture media supplement that improves the growth and productivity of CHO cells. Developed for scientists seeking maximum CHO cell culture performance, Zap-CHO is an animal free, well defined and consistent recombinant CHO supplement.

Fort Collins, CO (PRWEB) December 16, 2009 -- Scientists working with CHO cells can now access an informational online video featuring a presentation by Dr. Steve Pettit, InVitria’s Director of Cell Culture Product Development. Zap-CHO is a robust CHO cell supplement that maximizes CHO cell line performance and speeds-up cell line development processes. Zap-CHO is not a hydrolysate; it is an animal free, well defined and consistent recombinant CHO supplement.

Dr. Pettit guides viewers through the online video by describing the work done to test the effectiveness of Zap-CHO on CHO cell growth and productivity. “We tested Zap-CHO in the leading chemically-defined, serum- and protein-free cell culture media available on the market today,” said Dr. Pettit. “In our tests, Zap-CHO increased cell growth an average of 190% across all media and extended cell viability by delaying apoptosis. Most importantly, Zap-CHO increased volumetric productivity an average of 179%.”

In the video, Dr. Pettit points out the distinct advantages Zap-CHO gives scientists who are trying to improve their CHO cell line performance, including:

 
  • Faster cell growth
  • Higher peak cell density
  • Reduced apoptosis
  • Increased viability
  • Maximized productivity
  • Easy removal by Protein A chromatography during downstream purification

Further, Zap-CHO helps scientists working in clone selection by improving growth and shortening timelines; in seed train expansion by reducing the amount of time from cell bank to bioreactor; in cell adaptation by reducing the timelines for media adaptation; and, in bioproduction by maximizing antibody titre.

To watch the Zap-CHO product video click here.

To purchase Zap-CHO:
Call: 1-800-916-8311
Online: www.ZapCHO.com

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media supplements and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

# # #

Read the full story at http://www.prweb.com/releases/InVitriaZapCHOvideo/CHOcellculture/prweb3350724.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Mimotopes Launches Online Peptide Superstore
2. Life Science Firms are Turning to Firmex to do Deals Online
3. MedTrust Online Surpasses 5,000 Registered Users and Adds Dr. Henry Friedman to Oncology Advisory Board
4. Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician
5. Inspiring New Online Destination From Bayer Diabetes Care
6. Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)
7. New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix
8. MSNBC Publishes Free Online Abridgment of Biocentrism
9. Elsevier / MC Strategies Online Courses Named in the 15th Annual Communicator Awards
10. Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists
11. Drug Information Association Launches New 45th Annual Meeting Online
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 
(Date:4/28/2017)... ... April 28, 2017 , ... Cynvenio Biosystems, Inc. a leader ... neoadjuvant breast cancer monitoring (NEAT) study in partnership with Allentown, PA-based TME Research ... patients to be monitored over two years with Cynvenio’s ClearID Breast Cancer blood test. ...
(Date:4/27/2017)... and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) today announced that its ... $250 million of the company,s common stock. This program ... December 31, 2017. Purchases may be made in the ... transactions from time to time as determined by United ...
(Date:4/27/2017)... ... April 27, 2017 , ... Mitotech S.A, a Luxembourg based ... Optic Neuropathy (LHON) patients. LHON is a rare devastating genetic disease that leads to ... drops in a group of 20 patients carrying 11778, 14484 and 3460 mutations and ...
(Date:4/27/2017)... ... 27, 2017 , ... During the course of this webinar, ... 1,25-Dihydroxyvitamin D can enhance clinical practice. Participants will learn the medical indications and ... Dr. Gregory Plotnikoff, senior consultant with Minnesota Personalized Medicine, will be the speaker ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)...  On April 6-7, 2017, Sequencing.com will host the ... hackathon at Microsoft,s headquarters in Redmond, Washington ... developing health and wellness apps that provide a unique, ... is the first hackathon for personal genomics and ... in the genomics, tech and health industries are sending ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):